{"content":"<li class=\"n-box-item date-title\" data-end=\"1465876799\" data-start=\"1465790400\" data-txt=\"Sunday, December 22, 2019\">Monday, June 13, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3188643\" data-ts=\"1465858684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSLR\" target=\"_blank\">VSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188643-bloomberg-vivint-solar-seeking-300m-financing-package\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Vivint Solar seeking $300M financing package</a></h4><ul>     <li>Vivint Solar (NYSE:<a href=\"https://seekingalpha.com/symbol/VSLR\" title=\"Vivint Solar\">VSLR</a>) <font color=\"green\">+1.7%</font> AH following a Bloomberg report that it <a href=\"http://www.bloomberg.com/news/articles/2016-06-13/vivint-said-to-seek-300-million-for-rooftop-solar-operations\" target=\"_blank\">seeking a financing package of ~$300M</a> to grow its rooftop solar operations.</li>     <li>Investec reportedly is leading the deal for the funds are expected to refinance an existing credit line and help VSLR meet its April forecast of installing 260 MW of rooftop solar systems this year, up 12% from 2015.</li>     <li>VSLR has arranged several financing deals since its proposed acquisition by now-bankrupt SunEdison fell apart in March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188643\" data-linked=\"Bloomberg: Vivint Solar seeking $300M financing package\" data-tweet=\"$VSLR - Bloomberg: Vivint Solar seeking $300M financing package https://seekingalpha.com/news/3188643-bloomberg-vivint-solar-seeking-300m-financing-package?source=tweet\" data-url=\"https://seekingalpha.com/news/3188643-bloomberg-vivint-solar-seeking-300m-financing-package\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188635\" data-ts=\"1465854378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188635-baidu-issues-q2-warning-shares-tumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu issues Q2 warning; shares tumble</a></h4><ul>\n<li>Baidu (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a>) now expects Q2 revenue of RMB18.1B-RMB18.2B ($2.807B-$2.823B), below prior guidance of RMB20.11B-RMB20.58B and an RMB20.1B consensus.</li>\n<li>The Chinese search giant blames: 1) Ongoing <a href=\"https://seekingalpha.com/news/3178038-baidu-lower-chinese-regulators-initiate-probe\" target=\"_blank\">regulatory probes</a> of its online ad practices for \"medical, pharmaceutical, healthcare and other similar businesses,\" and stricter ad regulations for medical organizations. 2) <a href=\"http://www.bloomberg.com/news/articles/2016-05-09/baidu-to-restrict-sponsored-search-results-after-china-s-probe\" target=\"_blank\">Fewer sponsored links</a> on Baidu's online ad platform.</li>\n<li>Baidu adds regulatory probes are \"being rolled out with varied timing with different levels of implementation and interpretation across geographies,\" and that medical advertisers are delaying their spending as the probes continue. \"These customers may be in the process of receiving instruction from regulatory authorities, gathering and submitting required documentation and adjusting their practices to comply with new regulations.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a><font color=\"red\"> -7.4% </font>after hours to $151.39.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188635\" data-linked=\"Baidu issues Q2 warning; shares tumble\" data-tweet=\"$BIDU - Baidu issues Q2 warning; shares tumble https://seekingalpha.com/news/3188635-baidu-issues-q2-warning-shares-tumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3188635-baidu-issues-q2-warning-shares-tumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188628\" data-ts=\"1465851766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVNC\" target=\"_blank\">RVNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188628-revances-lead-product-candidate-flunks-late-stage-study-in-patients-crows-feet-shares-drop-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revance&#39;s lead product candidate flunks late-stage study in patients with crow&#39;s feet; shares drop 22% after hours</a></h4><ul>\n<li>Thinly traded micro cap Revance Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RVNC\" title=\"Revance Therapeutics, Inc.\">RVNC</a>) slumps <font color=\"red\">22%</font> after hours on robust volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1479290/000119312516620118/d175237dex991.htm\" target=\"_blank\">announcement </a>that lead product candidate DaxibotulinumtoxinA Topical Gel (RT001) flunked a Phase 3 study, REALISE 1, in patients with moderate-to-severe lateral canthal lines (crow's feet).</li>\n<li>Based on the disappointing results, the company has decided to terminate the clinical development of RT001 for axillary hyperhidrosis. Instead, it will focus on developing RT002, an injectable formulation of DaxibotulinumtoxinA, currently in Phase 2 development for cervical dystonia and Phase 3 for glabellar (frown) lines.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188628\" data-linked=\"Revance&#39;s lead product candidate flunks late-stage study in patients with crow&#39;s feet; shares drop 22% after hours\" data-tweet=\"$RVNC - Revance&#39;s lead product candidate flunks late-stage study in patients with crow&#39;s feet; shares drop 22% after hours https://seekingalpha.com/news/3188628-revances-lead-product-candidate-flunks-late-stage-study-in-patients-crows-feet-shares-drop-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3188628-revances-lead-product-candidate-flunks-late-stage-study-in-patients-crows-feet-shares-drop-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188619\" data-ts=\"1465849653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188619-immunogen-initiates-100m-convertible-debt-offering-shares-down-14-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen initiates $100M convertible debt offering; shares down 14% after hours</a></h4><ul>\n<li>ImmunoGen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a>) <a href=\"http://www.businesswire.com/news/home/20160613006402/en/ImmunoGen-Announces-Proposed-100-Million-Offering-Convertible\" target=\"_blank\">announces </a>plans for a $100M private offering of convertible senior notes due 2021. Price, yield and terms have yet to be announced.</li>\n<li>Net proceeds will fund operations, R&amp;D, capex, working capital and general corporate purposes.</li>\n<li>Shares are off <font color=\"red\">14%</font> after hours on increased volume.</li>\n<li>\n<strong>Update</strong>: On June 15, the company <a href=\"http://www.businesswire.com/news/home/20160615005791/en/ImmunoGen-Announces-Pricing-100-Million-Offering-4.50%C2%A0Convertible\" target=\"_blank\">announced </a>that the 4.50% convertible senior notes due 2021 would be priced at par. Initial purchasers have a 30-day option to buy an additional $15M aggregate principal amount of the notes. The conversion rate, which could be adjusted at a later point in time, is 238.7775 shares per $1,000 principal amount (~$4.19 per share).</li>\n<li>Net proceeds should be $96.7M ($111.2M if initial purchasers fully exercise their option to buy more notes).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188619\" data-linked=\"ImmunoGen initiates $100M convertible debt offering; shares down 14% after hours\" data-tweet=\"$IMGN - ImmunoGen initiates $100M convertible debt offering; shares down 14% after hours https://seekingalpha.com/news/3188619-immunogen-initiates-100m-convertible-debt-offering-shares-down-14-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3188619-immunogen-initiates-100m-convertible-debt-offering-shares-down-14-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188611\" data-ts=\"1465847972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188611-cathay-pacific-starts-two-year-program-to-use-amaris-renewable-jet-fuel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cathay Pacific starts two-year program to use Amaris renewable jet fuel</a></h4><ul>     <li>Amyris (<a href=\"https://seekingalpha.com/symbol/AMRS\" title=\"Amyris, Inc.\">AMRS</a> <font color=\"green\">+9.3%</font>) is higher after announcing earlier that Cathay Pacific has started a two-year program of flights from Toulouse to Hong Kong using the company's renewable jet fuel.</li>     <li>AMRS says the initial 12-hour flight was the longest flight yet using a renewable jet fuel and further underpins the \u2018drop-in\u2019 characteristics of  its biojet fuels.</li>     <li>AMRS, in partnership with Total (<a href=\"https://seekingalpha.com/symbol/TOT\" title=\"TOTAL S.A.\">TOT</a> <font color=\"red\">-1.5%</font>), has created a sustainable sugar cane-derived, farnesene-based renewable jet fuel, and AMRS says the flights represent another step toward projected long-term demand for farnesene  for a variety of renewable products.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188611\" data-linked=\"Cathay Pacific starts two-year program to use Amaris renewable jet fuel\" data-tweet=\"$AMRS $AMRS $TOT - Cathay Pacific starts two-year program to use Amaris renewable jet fuel https://seekingalpha.com/news/3188611-cathay-pacific-starts-two-year-program-to-use-amaris-renewable-jet-fuel?source=tweet\" data-url=\"https://seekingalpha.com/news/3188611-cathay-pacific-starts-two-year-program-to-use-amaris-renewable-jet-fuel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188598\" data-ts=\"1465845640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188598-technology-top-5-gainers-losers-of-3-20-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:20 pm</a></h4><ul> <li><b>Gainers:</b> LNKD <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+7%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/XCOM' title='Xtera Communications'>XCOM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd.'>BCOM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/IMI' title='Intermolecular, Inc.'>IMI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CEL' title='Cellcom Israel, Ltd.'>CEL</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188598\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:20 pm\" data-tweet=\"$MSFT $HMNY $MOBL - Technology - Top 5 Gainers / Losers as of 3:20 pm https://seekingalpha.com/news/3188598-technology-top-5-gainers-losers-of-3-20-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3188598-technology-top-5-gainers-losers-of-3-20-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188597\" data-ts=\"1465845438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGL\" target=\"_blank\">NGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188597-ngl-energy-partners-upgraded-to-buy-wunderlich\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NGL Energy Partners upgraded to Buy at Wunderlich</a></h4><ul>     <li>NGL Energy Partners (<a href=\"https://seekingalpha.com/symbol/NGL\" title=\"NGL Energy Partners LP\">NGL</a> <font color=\"green\">+2%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8104651/wunderlich-upgrades-ngl-energy-partners-to-buy-on-future\" target=\"_blank\">upgraded to Buy</a> from Hold with a $20 price target, raised from $13, at Wunderlich, which cites a potentially sizable distribution step-up in FY 2018 and reasonable valuation.</li>     <li>The firm thinks NGL's refined products business should continue to outperform given increasing motor fuels demand and relatively low prices, while a reversion to the mean of winter weather should benefit retail propane.</li>     <li>The firm believes stabilization in WTI prices should provide a basis to collect on Grand Mesa volumes and cash flows, and says excess cash flow and acceptable leverage should offset headwinds in water volumes and crude marketing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188597\" data-linked=\"NGL Energy Partners upgraded to Buy at Wunderlich\" data-tweet=\"$NGL - NGL Energy Partners upgraded to Buy at Wunderlich https://seekingalpha.com/news/3188597-ngl-energy-partners-upgraded-to-buy-wunderlich?source=tweet\" data-url=\"https://seekingalpha.com/news/3188597-ngl-energy-partners-upgraded-to-buy-wunderlich\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188583\" data-ts=\"1465841156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188583-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/RKDA\" title=\"Arcadia Biosciences\">RKDA</a> <font color=\"green\">+42%</font>. <a href=\"https://seekingalpha.com/symbol/TRQ\" title=\"Turquoise Hill Resources Ltd.\">TRQ</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ALDW\" title=\"Alon USA Partners\">ALDW</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/FSI\" title=\"Flexible Solutions International, Inc\">FSI</a> <font color=\"green\">+8%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/GBR\" title=\"New Concept Energy, Inc.\">GBR</a> <font color=\"red\">-29%</font>. <a href=\"https://seekingalpha.com/symbol/EMES\" title=\"Emerge Energy Services LP\">EMES</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/FMSA\" title=\"Fairmount Santrol, Inc.\">FMSA</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/APLP\" title=\"Archrock Partners, L.P.\">APLP</a> <font color=\"red\">-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188583\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$RKDA $TRQ $IPI - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3188583-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3188583-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188581\" data-ts=\"1465840274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188581-theme-parks-stocks-lower-after-orlando-attack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Theme parks stocks lower after Orlando attack</a></h4><ul> <li>SeaWorld Entertainment (<a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a> <font color='red'>-2.7%</font>), Cedar Fair (<a href='https://seekingalpha.com/symbol/FUN' title='Cedar Fair, L.P.'>FUN</a> <font color='red'>-0.8%</font>), and Six Flags (<a href='https://seekingalpha.com/symbol/SIX' title='Six Flags Entertainment Corporation'>SIX</a> <font color='red'>-0.6%</font>) all trade lower after reports indicate that the Orlando gunman scouted Disney World as a potential target.</li> <li>Theme park stocks have slid in the past off of terrorism fears only to quickly recover.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3188581\" data-linked=\"Theme parks stocks lower after Orlando attack\" data-tweet=\"$SEAS $SEAS $FUN - Theme parks stocks lower after Orlando attack https://seekingalpha.com/news/3188581-theme-parks-stocks-lower-after-orlando-attack?source=tweet\" data-url=\"https://seekingalpha.com/news/3188581-theme-parks-stocks-lower-after-orlando-attack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188572\" data-ts=\"1465837116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UGP\" target=\"_blank\">UGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188572-brazil-fuel-distributor-ultrapar-buys-smaller-rival-petrobras-plunges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil fuel distributor Ultrapar buys smaller rival; Petrobras plunges</a></h4><ul>     <li>Ultrapar (<a href=\"https://seekingalpha.com/symbol/UGP\" title=\"Ultrapar Participacoes S.A.\">UGP</a> <font color=\"green\">+3.7%</font>), Brazil's second-biggest fuel distributor, jumps ~4% after <a href=\"http://www.reuters.com/article/ale-ma-ultrapar-idUSL1N1940DM\" target=\"_blank\">agreeing to acquire</a> smaller peer Alesat Combustíveis for 2.17B reais ($635M) in a move that makes it more competitive with Petrobras' (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"red\">-2.8%</font>) distribution unit.</li>     <li>UPR\u2019s Ipiranga fuel distribution unit already had more than 7,200 gas stations across Brazil, and the combined company adds another 2K stations to <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2016/06/13/brazils-ultrapar-up-4-on-ma-petrobras-sinks/?mod=BOL_hp_blog_em\" target=\"_blank\">bring its market share near 18%</a>, approaching PBR's market leading BR Distribuidora's nearly 20% market share from 7,500 service stations.</li>     <li>PBR has said it wants to sell at least 25% of  its  distribution unit to a strategic partner as part of its plan to sell $15B of assets to pay down debt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188572\" data-linked=\"Brazil fuel distributor Ultrapar buys smaller rival; Petrobras plunges\" data-tweet=\"$UGP $UGP $PBR - Brazil fuel distributor Ultrapar buys smaller rival; Petrobras plunges https://seekingalpha.com/news/3188572-brazil-fuel-distributor-ultrapar-buys-smaller-rival-petrobras-plunges?source=tweet\" data-url=\"https://seekingalpha.com/news/3188572-brazil-fuel-distributor-ultrapar-buys-smaller-rival-petrobras-plunges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188570\" data-ts=\"1465836583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPG\" target=\"_blank\">WPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188570-wp-glimcher-shoots-down-takeover-rumor-slips-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WP Glimcher shoots down takeover rumor, slips 7%</a></h4><ul>\n<li>Noting it's not company policy to comment on speculation, WP Glimcher (<a href=\"https://seekingalpha.com/symbol/WPG\" title=\"Washington Prime Group, Inc.\">WPG</a> <font color=\"red\">-7.2%</font>) nevertheless says it's not in talks involving a merger or any other strategic alternative with any third parties.</li>\n<li>The stock shot higher last week on a report the company<a href=\"https://seekingalpha.com/news/3188041-reuters-kite-realty-wp-glimcher-merger-talks\" target=\"_blank\"> was in talks</a> about a sale to Kite Realty Group (<a href=\"https://seekingalpha.com/symbol/KRG\" title=\"Kite Realty Group Trust\">KRG</a> <font color=\"green\">+4.2%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188570\" data-linked=\"WP Glimcher shoots down takeover rumor, slips 7%\" data-tweet=\"$WPG $WPG $KRG - WP Glimcher shoots down takeover rumor, slips 7% https://seekingalpha.com/news/3188570-wp-glimcher-shoots-down-takeover-rumor-slips-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3188570-wp-glimcher-shoots-down-takeover-rumor-slips-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188567\" data-ts=\"1465835841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188567-fda-oks-protocol-for-late-stage-study-of-catalyst-pharmas-firdapse-in-lems-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs protocol for late-stage study of Catalyst Pharma&#39;s Firdapse in LEMS; shares up 8%</a></h4><ul>\n<li>Micro cap Catalyst Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+6.9%</font>) is up on more than double normal volume in response to its announcement that it has reached agreement with the FDA on the protocol for its Phase 3 confirmatory study assessing Firdapse (amifampridine phosphate) for the treatment of <a href=\"http://emedicine.medscape.com/article/1170810-overview\" target=\"_blank\">Lambert-Eaton myasthenic syndrome</a> (LEMS), an autoimmune disorder characterized by muscle weakness in the legs, face and neck. A small single-center study, part of the protocol, is expected to commence later this year.</li>\n<li>Several months ago, the company received a \"Refusal to File\" letter from the FDA in response to its New Drug Application (NDA) meaning that the filing was incomplete and would require additional clinical data.</li>\n<li>\n<a href=\"http://catalystpharma.com/pdf/CPP14005_ANAPoster_RD19M.pdf\" target=\"_blank\">Amifampridine</a> enhances neuromuscular transmission by blocking the potassium channel. This causes depolarization of the presynaptic membranes which opens the calcium channel thereby enabling muscle fibers to contract.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3175784-catalyst-pharma-48-percent-fda-says-new-phase-3-study-needed-firdapse-nda\" target=\"_blank\">Catalyst Pharma down 48% after FDA says new Phase 3 study needed for Firdapse NDA</a> (April 26)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188567\" data-linked=\"FDA OKs protocol for late-stage study of Catalyst Pharma&#39;s Firdapse in LEMS; shares up 8%\" data-tweet=\"$CPRX - FDA OKs protocol for late-stage study of Catalyst Pharma&#39;s Firdapse in LEMS; shares up 8% https://seekingalpha.com/news/3188567-fda-oks-protocol-for-late-stage-study-of-catalyst-pharmas-firdapse-in-lems-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3188567-fda-oks-protocol-for-late-stage-study-of-catalyst-pharmas-firdapse-in-lems-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188566\" data-ts=\"1465835351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBE\" target=\"_blank\">OBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188566-penn-westplus-44-after-buyer-pays-15x-debt-adjusted-cash-flow-for-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penn West +44% after buyer pays 15x debt-adjusted cash flow for assets</a></h4><ul>     <li>Penn West Petroleum (PWE <font color=\"green\">+44.5%</font>) surges more than 40% following <a href=\"https://seekingalpha.com/news/3188429-penn-west-sell-saskatchewan-assets-teine-energy-c-975m\" target=\"_blank\">late Friday's news</a> that it agreed to sell all of its Saskatchewan assets, including its Dodsland Viking area, for $975M.</li>     <li>\u201cThe sale is a definitive step which will help to change the narrative from constant discussions around its debt toward constructive conversations around Penn West\u2019s recent performance in its remaining Cardium area,\u201d Raymond James analyst Jeremy McCrea writes as he <a href=\"http://www.bloomberg.com/news/articles/2016-06-13/penn-west-jumps-most-since-1992-after-teine-agrees-to-buy-assets\" target=\"_blank\">upgrades shares</a> to Outperform from Sell.</li>     <li>PWE says it will now target growing its Cardium and Viking positions in Alberta and plans to continue selling assets outside its primary areas of focus; PWE\u2019s Cardium oil wells have been some of the best revenue generators in the Canadian industry over the last year, Raymond James says.</li>     <li>PWE got an attractive price for the properties, reflecting closely-held Teine Energy\u2019s ability to pay up, with Teine paying ~15x the debt adjusted cash flow of the assets vs. recent deals of ~7x, Desjardins Capital says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188566\" data-linked=\"Penn West +44% after buyer pays 15x debt-adjusted cash flow for assets\" data-tweet=\"$OBE - Penn West +44% after buyer pays 15x debt-adjusted cash flow for assets https://seekingalpha.com/news/3188566-penn-westplus-44-after-buyer-pays-15x-debt-adjusted-cash-flow-for-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3188566-penn-westplus-44-after-buyer-pays-15x-debt-adjusted-cash-flow-for-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188565\" data-ts=\"1465834612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188565-nvidia-gains-nomura-upgrades-on-data-center-opportunities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia gains as Nomura upgrades on data center opportunities</a></h4><ul>\n<li>Upbeat on the potential of the company's data center/server GPU business following a talk with CEO Jen-Hsun Huang, Nomura's Romit Shah <a href=\"http://blogs.barrons.com/techtraderdaily/2016/06/13/nvidia-nomura-ups-to-buy-after-ceos-bullish-data-center-remarks\" target=\"_blank\">has upgraded</a> Nvidia (<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"green\">+2.3%</font>) to Buy, and upped his target by $20 to $55.</li>\n<li>Shah: \"Mr. Huang was very enthusiastic about the prospects for the Datacenter business, as Hyperscale companies quickly adopt throughput computing in an effort to accelerate workload performance. Datacenter revenues grew 63% yoy last quarter due to broad adoption for <a href=\"http://www.nvidia.com/object/tesla-m40.html\" target=\"_blank\">Nvidia\u2019s M40</a> product, a GPU accelerator. We believe that NVDA has an 80% share in the accelerator market, which makes up less than 1% of total datacenter spending.\"</li>\n<li>He adds engagement for Nvidia-powered autopilot solutions for cars (now above 80) will boost automotive revenue later this year. Shah's target is equal to a 4.5x <a href=\"http://www.investopedia.com/terms/e/enterprisevaluesales.asp\" target=\"_blank\">EV/sales</a> ratio.</li>\n<li>Nvidia soared last month after strong earnings/guidance that were fueled by surging Tesla server graphics card sales, as well as rising Tegra processor sales within the automotive infotainment market. Facebook, Microsoft, Alibaba, and other web/cloud giants are believed to be Tesla clients.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188565\" data-linked=\"Nvidia gains as Nomura upgrades on data center opportunities\" data-tweet=\"$NVDA - Nvidia gains as Nomura upgrades on data center opportunities https://seekingalpha.com/news/3188565-nvidia-gains-nomura-upgrades-on-data-center-opportunities?source=tweet\" data-url=\"https://seekingalpha.com/news/3188565-nvidia-gains-nomura-upgrades-on-data-center-opportunities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188554\" data-ts=\"1465831763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188554-report-rio-tinto-looking-to-expand-exposure-to-turquoise-hill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Rio Tinto looking to expand exposure to Turquoise Hill</a></h4><ul>     <li>Rio Tinto (<a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"green\">+0.9%</font>) is <a href=\"http://www.thetimes.co.uk/article/rio-eyes-8bn-copper-deal-xbw3rwhgj\" target=\"_blank\">looking to increase its stake</a> in Turquoise Hill Resources (<a href=\"https://seekingalpha.com/symbol/TRQ\" title=\"Turquoise Hill Resources Ltd.\">TRQ</a> <font color=\"green\">+12.8%</font>) and have the rest of the company acquired by a single strategic buyer or consortium, <em>Sunday Times</em> reports.</li>     <li>Rio already owns 51% of TRQ and has hired Goldman Sachs as an adviser to help it privatize the business with the assistance of a partner, according to the report.</li>     <li>TRQ <a href=\"http://www.afr.com/business/mining/rio-tinto-eyeing-us6-billion-copper-deal-in-mongolia-20160612-gphi3e\" target=\"_blank\">owns 66% of Oyu Tolgoi</a>, the huge copper,  silver and gold mine in Mongolia that Deutsche Bank's Paul Young has described as, \"the best undeveloped copper project globally and probably the best undeveloped asset in the industry.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188554\" data-linked=\"Report: Rio Tinto looking to expand exposure to Turquoise Hill\" data-tweet=\"$RIO $RIO $TRQ - Report: Rio Tinto looking to expand exposure to Turquoise Hill https://seekingalpha.com/news/3188554-report-rio-tinto-looking-to-expand-exposure-to-turquoise-hill?source=tweet\" data-url=\"https://seekingalpha.com/news/3188554-report-rio-tinto-looking-to-expand-exposure-to-turquoise-hill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188547\" data-ts=\"1465829698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AP\" target=\"_blank\">AP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188547-ampco-pittsburgh-lower-on-price-increases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampco-Pittsburgh lower on price increases</a></h4><ul>\n<li>Ampco-Pittsburgh (<a href=\"https://seekingalpha.com/symbol/AP\" title=\"Ampco-Pittsburgh Corporation\">AP</a> <font color=\"red\">-4.7%</font>) unit, Union Electric Steel Corporation, will raise prices on forged and cast roll products that it and its subsidiaries produce globally.</li>\n<li>The increase is effective July 1, 2016, or as relevant contract terms permit.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188547\" data-linked=\"Ampco-Pittsburgh lower on price increases\" data-tweet=\"$AP - Ampco-Pittsburgh lower on price increases https://seekingalpha.com/news/3188547-ampco-pittsburgh-lower-on-price-increases?source=tweet\" data-url=\"https://seekingalpha.com/news/3188547-ampco-pittsburgh-lower-on-price-increases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188544\" data-ts=\"1465829337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188544-nokia-gains-after-signing-1_5b-framework-deal-china-mobile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia gains after signing a $1.5B framework deal with China Mobile</a></h4><ul>\n<li>Nokia (<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"green\">+2.6%</font>) <a href=\"http://company.nokia.com/en/news/press-releases/2016/06/13/nokia-and-china-mobile-sign-eur-136-billion-frame-agreement\" target=\"_blank\">has signed</a> a one-year, \u20ac1.36B ($1.5B) framework agreement with China Mobile.</li>\n<li>As part of the framework agreement, Nokia will \"continue delivery of mobile, fixed, IP routing, optical transport, customer experience management technologies and operational support as well as global services.\" Also, China Mobile will be the first carrier to deploy Nokia's <a href=\"http://networks.nokia.com/portfolio/products/airscale-radio-access\" target=\"_blank\">AirScale</a> base stations, which support multiple air interfaces (including, eventually, 5G radios).</li>\n<li>Both Nokia and recently-acquired Alcatel-Lucent <a href=\"https://seekingalpha.com/news/1240002-china-mobile-hands-out-3_2b-worth-of-4g-orders\" target=\"_blank\">have been suppliers</a> to China Mobile for some time. However, local equipment vendors Huawei and ZTE have an outsized share of the Chinese mobile infrastructure market.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188544\" data-linked=\"Nokia gains after signing a $1.5B framework deal with China Mobile\" data-tweet=\"$NOK - Nokia gains after signing a $1.5B framework deal with China Mobile https://seekingalpha.com/news/3188544-nokia-gains-after-signing-1_5b-framework-deal-china-mobile?source=tweet\" data-url=\"https://seekingalpha.com/news/3188544-nokia-gains-after-signing-1_5b-framework-deal-china-mobile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188536\" data-ts=\"1465828414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOY\" target=\"_blank\">JOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188536-joy-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Joy on the move</a></h4><ul><li>A late rally? Joy Global (NYSE:<a href='https://seekingalpha.com/symbol/JOY' title='Joy Global Inc.'>JOY</a>) <font color='red'>sank 1.7%</font> in Friday's trading session despite an <a href=\"https://seekingalpha.com/news/3188364-joy-global-upgraded-buy-fbr-firmer-revenue-outlook\" target=\"_blank\">upgrade</a> at FBR Capital due to a firmer sales outlook.</li><li>JOY shares are now making their way into the green, <font color='green'>up 4.5%</font> in early trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3188536\" data-linked=\"Joy on the move\" data-tweet=\"$JOY - Joy on the move https://seekingalpha.com/news/3188536-joy-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3188536-joy-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188535\" data-ts=\"1465828281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188535-fireeye-gains-after-symantec-buys-blue-coat-for-4_65b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye gains after Symantec buys Blue Coat for $4.65B</a></h4><ul>\n<li>FireEye (<a href=\"https://seekingalpha.com/symbol/FEYE\" title=\"FireEye, Inc.\">FEYE</a> <font color=\"green\">+3%</font>) has caught a bid after <a href=\"https://seekingalpha.com/news/3188440-symantec-buying-blue-coat-4_65b-new-ceo-named\" target=\"_blank\">Symantec announced</a> it's buying web/cloud security hardware and software firm Blue Coat for $4.65B, or over 90% more than what P-E firm Bain paid for Blue Coat last year.</li>\n<li>There's been <a href=\"http://www.bloomberg.com/gadfly/articles/2016-05-06/fireeye-s-depressed-valuation-makes-it-a-vulnerable-target?cmpid=yhoo.headline\" target=\"_blank\">speculation</a> FireEye will draw M&amp;A interest, given its shares trade at a small fraction of their 2014 high and the company still maintains strong positions in multiple security tech fields. Cisco and IBM have been mentioned as potential suitors.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188535\" data-linked=\"FireEye gains after Symantec buys Blue Coat for $4.65B\" data-tweet=\"$FEYE - FireEye gains after Symantec buys Blue Coat for $4.65B https://seekingalpha.com/news/3188535-fireeye-gains-after-symantec-buys-blue-coat-for-4_65b?source=tweet\" data-url=\"https://seekingalpha.com/news/3188535-fireeye-gains-after-symantec-buys-blue-coat-for-4_65b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188533\" data-ts=\"1465827480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188533-netflix-higher-amid-buzz-for-stranger-things\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix higher amid buzz for Stranger Things</a></h4><ul> <li>Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+2.8%</font>) rallies in early trading to make up some ground lost during last week's slow decline.</li> <li>The company's trailer for upcoming supernatural series <em>Stranger Things</em> continues to create some strong buzz across social media networks.</li> <li><a href=\"http://www.theverge.com/2016/6/9/11895058/stranger-things-netflix-series-trailer-stephen-king\" target=\"_blank\">The Verge</a> says the show \"exudes\" the influence of Stephen King and Steven Spielberg in what can't be a boring amalgam.</li> <li>Stranger Things will be available for streaming on July 15.</li> <li><a href=\"https://www.youtube.com/watch?v=XWxyRG_tckY\" target=\"_blank\">Stranger Things trailer</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3188533\" data-linked=\"Netflix higher amid buzz for Stranger Things\" data-tweet=\"$NFLX - Netflix higher amid buzz for Stranger Things https://seekingalpha.com/news/3188533-netflix-higher-amid-buzz-for-stranger-things?source=tweet\" data-url=\"https://seekingalpha.com/news/3188533-netflix-higher-amid-buzz-for-stranger-things\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188531\" data-ts=\"1465827172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSUR\" target=\"_blank\">OSUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188531-orasure-slumps-11-on-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OraSure slumps 11% on downgrade</a></h4><ul><li>Micro cap OraSure Technologies (<a href=\"https://seekingalpha.com/symbol/OSUR\" title=\"OraSure Technologies, Inc.\">OSUR</a> <font color=\"red\">-11.1%</font>) eases on average volume in apparent response a <a href=\"http://www.americanbankingnews.com/2016/06/13/orasure-technologies-inc-osur-downgraded-by-raymond-james/\" target=\"_blank\">downgrade </a>to Market Perform from Outperform by Raymond James. Its price target is $8 (16% upside).</li></ul><div class=\"tiny-share-widget\" data-id=\"3188531\" data-linked=\"OraSure slumps 11% on downgrade\" data-tweet=\"$OSUR - OraSure slumps 11% on downgrade https://seekingalpha.com/news/3188531-orasure-slumps-11-on-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3188531-orasure-slumps-11-on-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188525\" data-ts=\"1465826257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEA\" target=\"_blank\">CEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188525-airline-stocks-weak-after-orlando-shooting-and-shanghai-bombing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks weak after Orlando shooting and Shanghai bombing</a></h4><ul> <li>Airline stocks begin the week with a sharp downward movement.</li> <li>The terror attack in Orlando is the main driver of the selling pressure on the sector, although a bombing in the Shanghai airport yesterday is also impacting Chinese airlines China Eastern Air (<a href=\"https://seekingalpha.com/symbol/CEA\" title=\"China Eastern Airlines Corporation Limited\">CEA</a> <font color=\"red\">-2.1%</font>) and China Southern Airlines (<a href=\"https://seekingalpha.com/symbol/ZNH\" title=\"China Southern Airlines Company Limited\">ZNH</a> <font color=\"red\">-5.3%</font>).</li> <li>Decliners include Hawaiian Holdings (<a href=\"https://seekingalpha.com/symbol/HA\" title=\"Hawaiian Holdings, Inc.\">HA</a> <font color=\"red\">-3.1%</font>), American Airlines Group (<a href=\"https://seekingalpha.com/symbol/AAL\" title=\"American Airlines Group\">AAL</a> <font color=\"red\">-2.9%</font>), Spirit Airlines (<a href=\"https://seekingalpha.com/symbol/SAVE\" title=\"Spirit Airlines\">SAVE</a> <font color=\"red\">-3.8%</font>), Delta Air Lines (<a href=\"https://seekingalpha.com/symbol/DAL\" title=\"Delta Air Lines, Inc.\">DAL</a> <font color=\"red\">-2.7%</font>), JetBlue (<a href=\"https://seekingalpha.com/symbol/JBLU\" title=\"JetBlue Airways Corporation\">JBLU</a> <font color=\"red\">-2.1%</font>), Southwest Airlines (<a href=\"https://seekingalpha.com/symbol/LUV\" title=\"Southwest Airlines Co.\">LUV</a> <font color=\"red\">-2.5%</font>), SkyWest (<a href=\"https://seekingalpha.com/symbol/SKYW\" title=\"SkyWest, Inc.\">SKYW</a> <font color=\"red\">-1.8%</font>), United Continental (<a href=\"https://seekingalpha.com/symbol/UAL\" title=\"United Continental Holdings, Inc\">UAL</a> <font color=\"red\">-2.6%</font>), Alaska Air Group (<a href=\"https://seekingalpha.com/symbol/ALK\" title=\"Alaska Air Group, Inc.\">ALK</a> <font color=\"red\">-2.3%</font>), and Allegiant Travel (<a href=\"https://seekingalpha.com/symbol/ALGT\" title=\"Allegiant Travel Company\">ALGT</a> <font color=\"red\">-1.5%</font>).</li> <li>The U.S. Global Jets ETF (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/JETS\" title=\"U.S. Global Jets ETF\">JETS</a>) is <font color=\"red\">down 2.72%</font> on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188525\" data-linked=\"Airline stocks weak after Orlando shooting and Shanghai bombing\" data-tweet=\"$CEA $CEA $ZNH - Airline stocks weak after Orlando shooting and Shanghai bombing https://seekingalpha.com/news/3188525-airline-stocks-weak-after-orlando-shooting-and-shanghai-bombing?source=tweet\" data-url=\"https://seekingalpha.com/news/3188525-airline-stocks-weak-after-orlando-shooting-and-shanghai-bombing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188521\" data-ts=\"1465825994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188521-emerge-energy-frac-sand-names-downgraded-da-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerge Energy, other frac sand names downgraded at DA Davidson</a></h4><ul>     <li>Emerge Energy Services (<a href=\"https://seekingalpha.com/symbol/EMES\" title=\"Emerge Energy Services LP\">EMES</a> <font color=\"red\">-8.3%</font>) opens sharply lower as DA Davidson <a href=\"http://thefly.com/landingPageNews.php?id=2387687&amp;headline=EMES-Emerge-Energy-downgraded-to-Underperform-from-Buy-at-DA-Davidson\" target=\"_blank\">downgrades</a> shares to Underperform from Buy with a $5 price target, saying frac sand names are trading \"well ahead of fundamentals for a growing industry that is still in flux.\"</li>     <li>The firm views the recent surge in valuations (<a href=\"https://seekingalpha.com/news/3188399-emerge-energy-continues-gain-stifel-says-worst\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3188195-emerge-energy-plus-30-percent-reach-highest-level-since-september\" target=\"_blank\">II</a>) and estimates for the frac sand group as \"devoid of reality,\" citing sell-side inconsistencies about the space including assuming anything is normalized in an industry that is relatively new and never been in a steady  state and assuming peak margins do not equate to painfully compressed  multiples.</li>     <li>Davidson also downgrades U.S. Silica (<a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a> <font color=\"red\">-3.5%</font>) to Neutral from Buy, as well as Hi-Crush Partners (<a href=\"https://seekingalpha.com/symbol/HCLP\" title=\"Hi-Crush Partners LP\">HCLP</a> <font color=\"red\">-5.4</font>) and Fairmount Santrol (<a href=\"https://seekingalpha.com/symbol/FMSA\" title=\"Fairmount Santrol, Inc.\">FMSA</a> <font color=\"red\">-4.8%</font>) to Underperform from Buy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188521\" data-linked=\"Emerge Energy, other frac sand names downgraded at DA Davidson\" data-tweet=\"$EMES $EMES $SLCA - Emerge Energy, other frac sand names downgraded at DA Davidson https://seekingalpha.com/news/3188521-emerge-energy-frac-sand-names-downgraded-da-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/3188521-emerge-energy-frac-sand-names-downgraded-da-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188519\" data-ts=\"1465824669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188519-citron-goes-short-facebook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron goes short Facebook</a></h4><ul>\n<li>\"Facebook (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a>) is losing an extensive amount of relevancy,\" Citron's Andrew Left<a href=\"http://www.cnbc.com/2016/06/13/citrons-andrew-left-is-shorting-facebook.html\" target=\"_blank\"> tells CNBC</a>.</li>\n<li>His call, of course, comes as Microsoft this morning <a href=\"https://seekingalpha.com/news/3188504-microsoft-linkedin\" target=\"_blank\">announces its purchase</a> of LinkedIn for a near-50% premium to Friday's close. Left told CNBC earlier this year he was long LinkedIn.</li>\n<li>Whereas LinkeIn is a \"monopoly in [its] respective space ... Facebook is losing market share to Snapchat and overstaying its welcome in other niches ... I am not saying Facebook is a bad company, [it] just will not be a $330B company in a year.\"</li>\n<li>FB <font color=\"red\">-1.4%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188519\" data-linked=\"Citron goes short Facebook\" data-tweet=\"$FB - Citron goes short Facebook https://seekingalpha.com/news/3188519-citron-goes-short-facebook?source=tweet\" data-url=\"https://seekingalpha.com/news/3188519-citron-goes-short-facebook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188510\" data-ts=\"1465824053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188510-agios-agminus-348-successful-in-mid-stage-study-in-rare-congenital-anemia-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios&#39; AG-348 successful in mid-stage study in rare congenital anemia; shares up 9% premarket</a></h4><ul>\n<li>Agios Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a>) jumps <font color=\"green\">9%</font> premarket on increased volume in response to its announcement of positive results in a Phase 2 clinical trial, DRIVE-PK, assessing <a href=\"http://www.agios.com/pipeline-pkr.php\" target=\"_blank\">AG-348</a> in patients with <a href=\"https://ghr.nlm.nih.gov/condition/pyruvate-kinase-deficiency\" target=\"_blank\">pyruvate kinase deficiency</a> (PKD), a rare and potentially debilitating inherited anemia. The data were presented at the 21st Congress of the European Hematology Association in Copenhagen.</li>\n<li>As of the March 27 data cutoff, 18 transfusion-dependent PKD patients were treated with AG-348 twice daily for up to six months. 50% (n=9/18) showed rapid and sustained increases in hemoglobin greater than 1.0 g/dL (range: 2.3 - 4.9 g/dL), including 69% (n=9/13) of patients with at least one <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/possiblemutations\" target=\"_blank\">missense mutation</a> (a type of mutation in one DNA base pair that results in the substitution of one amino acid for another in the protein made by the gene). About 80% of PKD patients carry at least one missense mutation.</li>\n<li>DRIVE-PK includes two arms of 25 subjects each, one receiving 50 mg of AG-348 twice daily and the other 300 mg twice daily. Of the nine patients who responded with an increase in hemoglobin at least 1.0 g/dL, four were in the 50 mg arm and five in the 300 mg arm. The median time to the increase was 1.9 weeks. None of the five patients with two non-missense mutations achieved the increase in hemoglobin.</li>\n<li>PKD presents like hemolytic anemia, characterized by the accelerated destruction of red blood cells. There are no approved therapies to treat the underlying cause of the disorder.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188510\" data-linked=\"Agios&#39; AG-348 successful in mid-stage study in rare congenital anemia; shares up 9% premarket\" data-tweet=\"$AGIO - Agios&#39; AG-348 successful in mid-stage study in rare congenital anemia; shares up 9% premarket https://seekingalpha.com/news/3188510-agios-agminus-348-successful-in-mid-stage-study-in-rare-congenital-anemia-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3188510-agios-agminus-348-successful-in-mid-stage-study-in-rare-congenital-anemia-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188515\" data-ts=\"1465823988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188515-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> EBIO <font color='green'>+96%</font>. LNKD <font color='green'>+49%</font>. <a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color='green'>+9%</font>. SWHC <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TRQ' title='Turquoise Hill Resources Ltd.'>TRQ</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188515\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$SESN $MSFT $AGIO - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3188515-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3188515-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188508\" data-ts=\"1465823143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWW\" target=\"_blank\">MWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188508-select-staffing-stocks-move-higher-after-linkedin-msft-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select staffing stocks move higher after LinkedIn-MSFT deal</a></h4><ul> <li>Shares of Monster Worldwide (NYSE:<a href=\"https://seekingalpha.com/symbol/MWW\" title=\"Monster Worldwide, Inc.\">MWW</a>) are <font color=\"green\">up 1.9%</font> and DHI Group (NYSE:<a href=\"https://seekingalpha.com/symbol/DHX\" title=\"DHI Group, Inc.\">DHX</a>) is <font color=\"green\">3.4% higher</font> after LinkedIn lands a giant takeover premium from Microsoft.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3188500-microsoft-buys-linkedin-26_2b\" target=\"_blank\">Microsoft buys LinkedIn for $26.2B</a> (June 13)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3188504-microsoft-linkedin\" target=\"_blank\">More Microsoft/LinkedIn</a> (June 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188508\" data-linked=\"Select staffing stocks move higher after LinkedIn-MSFT deal\" data-tweet=\"$MWW $MWW $DHX - Select staffing stocks move higher after LinkedIn-MSFT deal https://seekingalpha.com/news/3188508-select-staffing-stocks-move-higher-after-linkedin-msft-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3188508-select-staffing-stocks-move-higher-after-linkedin-msft-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188504\" data-ts=\"1465822384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188504-microsoft-linkedin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Microsoft/LinkedIn</a></h4><ul>\n<li>Microsoft (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a>) will <a href=\"http://news.microsoft.com/2016/06/13/microsoft-to-acquire-linkedin/#sm.00000ad2z02a0bf7jx8nqu6hgm8u2\" target=\"_blank\">fund the deal</a> mostly by issuing debt, with LinkedIn's (LNKD) results to be reported as part of MSFT's Productivity and Business Processes segment. EPS is expected to take a minimal hit in fiscals 2017 and 2018, but the deal should become accretive beginning in fiscal 2019.</li>\n<li>The purchase is expected to close this year.</li>\n<li>Microsoft still intends to complete its current $40B buyback plan by year-end.</li>\n<li>Jeff Weiner will remain CEO of LinkedIn, reporting to Microsoft chief Satya Nadella.</li>\n<li>Nadella: \"Together we can accelerate the growth of LinkedIn, as well as Microsoft Office 365 and Dynamics as we seek to empower every person and organization on the planet.\u201d</li>\n<li>A <a href=\"https://www.microsoft.com/en-us/Investor\" target=\"_blank\">conference call </a>is scheduled for 11:45 ET.</li>\n<li>LNKD remains <font color=\"green\">higher by 48.4%</font> to $194.49. Reopened for trade, MSFT is <font color=\"red\">lower by 3.6%</font>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3188500-microsoft-buys-linkedin-26_2b\" target=\"_blank\">Microsoft buys LinkedIn for $26.2B</a> (June 13)</li>\n<li>Twitter next? <a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> is <font color=\"green\">higher by 4%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188504\" data-linked=\"More Microsoft/LinkedIn\" data-tweet=\"$MSFT $MSFT $TWTR - More Microsoft/LinkedIn https://seekingalpha.com/news/3188504-microsoft-linkedin?source=tweet\" data-url=\"https://seekingalpha.com/news/3188504-microsoft-linkedin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188501\" data-ts=\"1465821687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188501-marinus-pharmas-lead-product-candidate-flunks-late-stage-study-shares-crater-59-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marinus Pharma&#39;s lead product candidate flunks late-stage study; shares crater 59% premarket</a></h4><ul>\n<li>Thinly traded micro cap Marinus Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a>) plummets <font color=\"red\">59% </font>premarket on robust volume in response to its announcement that a Phase 3 clinical trial assessing lead product candidate ganaxolone for the treatment of adults with drug-resistant focal onset seizures failed to demonstrate a statistically significant effect versus placebo, specifically the change in the 28-day seizure frequency from baseline (p=0.1537).</li>\n<li>As a result, the company will discontinue its development for the indication and focus its efforts on status epilepticus and other pediatric orphan conditions. Marinus will update investors on its clinical programs in the next few weeks.</li>\n<li>\n<a href=\"http://www.marinuspharma.com/#!ganaxolone/cxnj\" target=\"_blank\">Ganaxolone </a>is a small molecule inhibitor of the neurotransmitter GABA, which helps control epileptic seizures.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188501\" data-linked=\"Marinus Pharma&#39;s lead product candidate flunks late-stage study; shares crater 59% premarket\" data-tweet=\"$MRNS - Marinus Pharma&#39;s lead product candidate flunks late-stage study; shares crater 59% premarket https://seekingalpha.com/news/3188501-marinus-pharmas-lead-product-candidate-flunks-late-stage-study-shares-crater-59-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3188501-marinus-pharmas-lead-product-candidate-flunks-late-stage-study-shares-crater-59-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188500\" data-ts=\"1465821614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188500-microsoft-buys-linkedin-for-26_2b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft buys LinkedIn for $26.2B</a></h4><ul>\n<li>The all-cash deal for LinkedIn (LNKD) works out to $196 per share.</li>\n<li>LinkedIn is<font color=\"green\"> higher by 49%</font> premarket to $194.89. <a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a> is halted from trade.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188500\" data-linked=\"Microsoft buys LinkedIn for $26.2B\" data-tweet=\"$MSFT - Microsoft buys LinkedIn for $26.2B https://seekingalpha.com/news/3188500-microsoft-buys-linkedin-for-26_2b?source=tweet\" data-url=\"https://seekingalpha.com/news/3188500-microsoft-buys-linkedin-for-26_2b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>180&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188499\" data-ts=\"1465820778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188499-eleven-bio-inks-development-deal-roche-shares-up-61-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eleven Bio inks development deal with Roche; shares up 61% premarket</a></h4><ul>\n<li>Nano cap Eleven Biotherapeutics (EBIO) jumps <font color=\"green\">61%</font> premarket on robust volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1485003/000119312516619606/d135874dex991.htm\" target=\"_blank\">announcement </a>that it has entered into an exclusive license agreement with Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) to develop and commercialize <a href=\"http://www.elevenbio.com/pipeline/diabetic-macular-edema.html\" target=\"_blank\">EBI-031</a>, a humanized monoclonal antibody that binds to interleukin-6 (IL-6), for the treatment of ocular diseases, initially diabetic macular edema and uveitis.</li>\n<li>Under the terms of the contract, Eleven will receive an upfront cash payment of $7.5M, up to $262.5M in milestones and royalties on net sales of EBI-031 or any other future products containing other Eleven IL-6 compounds. The first milestone, $22.5M, will be triggered if the FDA approves the Investigational New Drug (IND) application no later than September 15 of this year (it was filed today). The milestone drops to $20.0M if the IND becomes effective afterward.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188499\" data-linked=\"Eleven Bio inks development deal with Roche; shares up 61% premarket\" data-tweet=\"$SESN $SESN $RHHBY - Eleven Bio inks development deal with Roche; shares up 61% premarket https://seekingalpha.com/news/3188499-eleven-bio-inks-development-deal-roche-shares-up-61-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3188499-eleven-bio-inks-development-deal-roche-shares-up-61-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188490\" data-ts=\"1465819207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188490-steel-dynamics-sees-better-expected-q2-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics sees better than expected Q2 earnings</a></h4><ul>\n<li>Steel Dynamics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/STLD\" title=\"Steel Dynamics, Inc.\">STLD</a>) <font color=\"green\">+3%</font> premarket after issuing upside guidance for Q2, now seeing EPS of $0.53-$0.57 vs. $0.45 analysts consensus estimate.</li>\n<li>STLD says it expects Q2 2016 profitability from its steel operations to nearly double Q1 results, based on improved metal spread and shipments, with the most significant improvement from flat roll operations.</li>\n<li>STLD says that for all of its steel operations, average quarterly realized  steel  product pricing is expected to rise ~10%, more than  offsetting additional costs derived from higher  priced ferrous scrap.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188490\" data-linked=\"Steel Dynamics sees better than expected Q2 earnings\" data-tweet=\"$STLD - Steel Dynamics sees better than expected Q2 earnings https://seekingalpha.com/news/3188490-steel-dynamics-sees-better-expected-q2-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3188490-steel-dynamics-sees-better-expected-q2-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188479\" data-ts=\"1465817662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188479-trading-in-marinus-pharma-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Marinus Pharma halted pending news</a></h4><ul>\n<li>Nasdaq has stopped trading in micro cap Marinus Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a>) pending news.</li>\n<li>The company's lead product candidate is Phase 3-stage ganaxolone for the adjunctive treatment of focal onset seizures in adult patients.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188479\" data-linked=\"Trading in Marinus Pharma halted pending news\" data-tweet=\"$MRNS - Trading in Marinus Pharma halted pending news https://seekingalpha.com/news/3188479-trading-in-marinus-pharma-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3188479-trading-in-marinus-pharma-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188472\" data-ts=\"1465816955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFSZF\" target=\"_blank\">GFSZF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188472-g4s-slumps-after-employee-identified-orlando-shooter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G4S slumps after employee identified as Orlando shooter</a></h4><ul> <li>Share of G4S (<a href=\"https://seekingalpha.com/symbol/GFSZF\" title=\"G4S Plc\">OTCPK:GFSZF</a>, <a href=\"https://seekingalpha.com/symbol/GFSZY\" title=\"G4S Plc ADR\">OTCPK:GFSZY</a>) are <font color=\"red\">down 7%</font> in London trading after <a href=\"http://metro.co.uk/2016/06/13/g4s-share-price-plummets-after-company-admits-employing-orlando-gunman-5940847/\" target=\"_blank\">reports</a> indicate the shooter in the Orlando terrorist attack worked as a security guard for the firm since 2007.</li>\n<li>The company says it's cooperating with the FBI in their investigation of Omar Mateen.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3188444-orlando-massacre-drives-gun-control-debate\" target=\"_blank\">Orlando massacre drives gun control debate</a> (June 13)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3188472\" data-linked=\"G4S slumps after employee identified as Orlando shooter\" data-tweet=\"$GFSZF $GFSZF $GFSZY - G4S slumps after employee identified as Orlando shooter https://seekingalpha.com/news/3188472-g4s-slumps-after-employee-identified-orlando-shooter?source=tweet\" data-url=\"https://seekingalpha.com/news/3188472-g4s-slumps-after-employee-identified-orlando-shooter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188462\" data-ts=\"1465814680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOS\" target=\"_blank\">BIOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188462-bioscrip-initiates-equity-offering-shares-off-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioScrip initiates equity offering; shares off 7% premarket</a></h4><ul>\n<li>Thinly traded micro cap BioScrip (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIOS\" title=\"BioScrip, Inc.\">BIOS</a>) is down <font color=\"red\">7%</font> premarket on light volume in response to its announcement that it has commenced a public offering of common stock. Price, volume and terms have yet to be released.</li>\n<li>\n<strong>Update</strong>: On June 17, the company announced that it was offering 40M shares at $2 per share. Underwriters over-allotment is an additional 5.2M shares. Net proceeds should be ~$73.4M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188462\" data-linked=\"BioScrip initiates equity offering; shares off 7% premarket\" data-tweet=\"$BIOS - BioScrip initiates equity offering; shares off 7% premarket https://seekingalpha.com/news/3188462-bioscrip-initiates-equity-offering-shares-off-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3188462-bioscrip-initiates-equity-offering-shares-off-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 AM </div></div></li>","count":35,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}